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Introduction
Primitive neuroectodermal tumors (PNETs) are small
round-cell tumors that often show neuroectodermal
differentiation. They can be either central or peripheral.
Central PNETs are derived from the neural tube
predominantly involving the brain or spinal cord.
Peripheral PNETs (pPNETs) are derived from the neural
crest involving the sympathetic nervous system, bone,
or soft tissue [1]. The most common site of pPNET in
the female genital tract is the ovary, reported in 27 cases
[2–4]. The uterus is the next most common site, with
14 cases reported to date [5]. Cervical, vaginal, and vul-
var pPNET are rare, with seven, four, and three cases
reported at each primary site, respectively [5–13]. To
the best of our knowledge, we report the first case of
uterine neuroectodermal tumor in Taiwan. We also
review the literature on this topic.
Case Report
A 52-year-old perimenopausal woman, gravida 5, para
3 (all term vaginal deliveries), spontaneous abortus 2,
had had a left ovarian tiny cyst and multiple small myo-
ma uteri since 1997. She received regular follow-up
examinations at our clinic without remarkable symp-
toms or signs. At one examination for Pap smear on
August 29, 2003, two adnexal masses (6.6 = 3.2 cm
and 5.5 = 4.2 cm) were found which suggested uter-
ine myoma. The results of the Pap smear were nor-
mal. Blood carcinoembryonic antigen was elevated
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(6.25 ng/mL) but the CA125 level was normal
(32.19 U/mL), as was the CA19-9 level (34.01 U/mL).
Her last menstrual period began on April 16, 2003.
Acute lower abdominal pain with intermittent dull
sensation occurred on October 10, 2003, and she
visited our clinic 3 days after the onset.
Pelvic examination revealed an enlarged uterus,
approximately the size of a fist, with severe tenderness.
Transvaginal ultrasound showed an ill-defined and
heterocomplex pelvic mass measuring 10.7 = 6.8 cm on
the anterior uterine wall and multiple uterine myomas
(3.9 = 3.9 cm, 4.6 = 3.9 cm, 3.9 = 3.4 cm, 1.5 = 1.0 cm).
Pelvic computed tomography (CT) with contrast me-
dium disclosed a huge heterogeneous tumor with
an irregular shape arising from the anterior wall of
the uterus (Figure 1).
The impression of malignant pelvic tumor and
multiple myoma led to exploratory laparotomy. After
opening the peritoneum, 20 mL of yellowish ascites was
found. A major friable and necrotic tumor measuring
11 = 13 = 6 cm arose from the anterior uterine wall
and extended to the bladder (Figure 2). The vesico-
uterine fold was severely adhesive so that there would
be bladder injury or even cystectomy if we performed
a hysterectomy. Bilateral ovaries and tubes were
atrophied and unremarkable. Multiple myoma uteri
were also noted. Another two major polypoid tumors
were located on the right posterior surface of the broad
ligament and left uterosacral ligament (3 = 3 cm and
2 = 3 cm, respectively). There were many small tumors
on the posterior wall of the uterus extending inferiorly
to the vagina. Partial tumor resection with postoperative
chemotherapy and radiation without hysterectomy
and cystectomy was planned to give her a good post-
operative quality of life. An intraoperative frozen sec-
tion was interpreted as malignant neoplasm with a
differential diagnosis of lymphoma, small cell carci-
noma, and stromal sarcoma.
Gross examination showed tumorous tissues,
yellow-white and elastically firm with a gelatinous cut
surface, measuring 13 = 11 = 6 cm and 4 = 3 = 1.5 cm.
There were focal myxoid changes. Microscopically,
the tissue was composed of monotonous hyper-
chromatic oval cells with a high nucleus/cytoplasm
ratio. No particular Homer-Wright pseudorosettes or
neuroectodermal differentiation was identified (Figure
Figure 2. The main tumor is yellow-white and elastic with
gelatinous content. Some focal myxoid changes are seen. It is
fragile, hemorrhagic, and necrotic and arises from the uterus
and measures approximately 13 = 11 cm. It is difficult to resect
completely.
Figure 1. Computed tomography with/without contrast
medium shows a huge heterogeneous tumor with irregular
shape arising from the anterior uterine wall. Small cystic
changes are seen.
Figure 3. Monotonous hyperchromatic oval cells have vesicular
nuclei with small nucleoli and scanty cytoplasm; focal tumor
necroses are seen (hematoxylin & eosin, = 200).
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3). Immunohistochemically, the tumor cells revealed
positive membranous staining for CD99 (O13 antibody)
(Figure 4) and some showed weakly positive reactivity
for smooth muscle actin. Other immunohistochemical
results including leukocyte common antigen, CD20,
CD45R0, vimentin, desmin and S100 were all nega-
tive. Final pathologic diagnosis was uterine PNET. No
malignant cells were found on washing cytology. Ac-
cording to the International Federation of Gynecology
and Obstetrics staging system for cancers of the uterine
corpus, this patient was diagnosed with at least stage III
disease. We could not rule out the tumors invading the
bladder mucosa because of microscopic hematuria
with 5–7 red blood cells/high-power field, although
cystoscopy was not performed preoperatively. Post-
operative recovery was uneventful but her family re-
fused any further treatment. At the next outpatient
department visit, there was a palpable abdominal mass
that grew rapidly and aggressively. The patient was
lost to follow-up 1 month after the last examination.
Discussion
The Ewing’s family of tumors is composed of Ewing’s
sarcoma (ES) and pPNETs. The latter term includes
different tumors, depending on their location and neu-
ral differentiation, such as peripheral neuroepithelio-
ma, Askin tumor, adult neuroblastoma, peripheral
neuroblastoma, and PNET. Approximately 83% of
cases with ES/PNETs present with the translocation
t(11;22)(q24;q12), which can be detected by reverse
transcription–polymerase chain reaction [14]. This
translocation results in the formation of a chimeric
gene, EWS/FLI1 [15], which may act as an alternative
transcriptional factor, potentially promoting onco-
genesis or malignant behavior in PNET and ES [16].
However, immunohistochemistry provides a more
convenient method to diagnose ES/pPNETs.
Most cases of uterine pPNET present with post-
menopausal bleeding, intermenstrual bleeding, an
enlarged uterus, or a pelvic mass [17], but our case
presented with acute lower abdominal pain without
abnormal vaginal bleeding. Spontaneous tumor rup-
ture is usually the cause of lower abdominal pain.
Perimenopausal status may mask abnormal vaginal
bleeding. However, there was no vaginal bleeding so
we could only suppose that the tumor might not have
involved the endometrium.
Mature glial tissue and neuroectoderm in the uterus
have been recorded secondary to incomplete therapeu-
tic abortion, or within a uterine teratoma. Benign neo-
plasms of neuroectodermal origin in the uterus include
neurofibroma, ganglioneuroma, and glioma, and these
usually arise in the uterine endocervix or endometrium
in women who typically present with intermenstrual
bleeding [18]. The histogenesis of PNETs of the uterus
remains unclear. They may evolve from ectopic neural
tissue or may represent differentiation of Mullerian
histogenesis [19]. One of three teenagers with uterine
pPNET had a history of pregnancy losses that made
some believe the tumors arose from implanted neu-
roectodermal fetal tissue or neuroectodermal mi-
grating cells [1,20–22]. However, an implanted neuro-
ectodermal fetal tissue origin seems unlikely because
most women with uterine PNETs are postmenopausal.
Our patient had had several uterine myomas for years
that may have masked the co-existence of uterine
PNET. No other mesodermal components or epithelial
elements were identified in our patient, precluding
the diagnosis of malignant mixed Mullerian tumors
(MMMTs). Mullerian derivations (mesodermal), such
as endometrial adenocarcinoma and sarcoma, were
also suggested by the admixture of PNETs. How-
ever, we did not obtain endometrium or uterine myo-
ma using fraction dilatation and curettage or hysterec-
tomy. The question of whether this malignancy arose
from uterine myoma and shifted to a neural differen-
tiated tumor remains unknown.
ES and pPNETs are related to malignant small,
round-blue cells. The diagnosis is sometimes difficult
using routine microscopy because of the nonspecific
histologic characteristics. However, membrane reac-
tivity to antibody O13 and identification of trans-
locations facilitate the diagnosis. In 2000, Sinkre et al
examined O13 immunoreactivity retrospectively in
40 cases of MMMTs [23]. No O13 immunoreactivity
Figure 4. Immunohistochemistry: tumor cells reveal diffuse
positive membranous staining of CD99 (O13).
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was seen in the malignant epithelium or in sarcoma-
tous components. The glycoprotein p30/32 (CD99)
is strongly expressed by ES/PNET (in nearly 90% of
cases) and is encoded by the MIC2 gene. CD99
reacts with O13 antibody, but we could not rule out
ES/pPNET in our case [23,24]. However, the presence
of glycoprotein p30/32 is nonspecific because it is
in several unrelated types of tumors, such as small-cell
carcinomas and sex cord-stromal tumors. Nonethe-
less, it is still a useful tool for the diagnosis of ES/
pPNETs. Most cases present with other nonspecific
immunohistochemical markers, including neuron-
specific enolase (NSE), vimentin, protein gene product
9.5, glial fibrillary acidic protein, S100, synaptophysin,
and Leu 7 [17,24]. The intensity and amount of tissue
reaction for these markers vary from case to case. These
tumors have some typical microscopic findings, such as
true rosettes with a central lumen, Homer-Wright
pseudorosettes, medulloepithelial tubules, glial or
ganglion or ganglion-like cells, and perivascular pali-
sading patterns [17,23].
In this case, ultrasound showed a heterocomplex
irregular pelvic mass, but it seemed like red degenera-
tion of the myoma. Despite other coexistent gyneco-
logic tumors, pPNET of the uterus has the character-
istics of easily focal necrosis so it often appears het-
erocomplex on sonography. The CT imaging charac-
teristics of PNETs, including other locations such as the
thoracic, abdominal, and pelvic regions, have not yet
been identified. All lesions are large and non-calcified
masses with heterogeneous appearance and with vari-
able enhancement with contrast medium on CT due
to cystic changes. However, imaging (magnetic reso-
nance imaging and CT) are useful for preoperative
evaluation [25].
The differential diagnosis of PNETs includes other
uterine tumors with characteristics of small malignant
cells including stromal sarcoma, lymphoma, and small-
cell neuroendocrine carcinoma. Endometrial stromal
sarcomas are composed of small cells and have a
prominent vascular pattern of spiral arteriole-like
spaces. Most have estrogen and progesterone re-
ceptors but no CD99 immunoreactivity. Lymphoma
involving the uterus may also be considered in the dif-
ferential diagnosis, but its immunohistochemical
findings differ from those of PNETs due to its lym-
phoid markers. Small-cell neuroendocrine carcino-
mas share most of their immunohistochemical pro-
file with pPNETs, which are positive for chromogranin,
synaptophysin, and NSE. However, as for lymphoma
and stromal sarcoma, they are also negative for
CD99 [5]. Tumors arising from the neural crest (or
peripheral nervous system) have also been encoun-
tered in the uterine corpus or cervix. These include
paraganglioma of typical and melanotic types, pig-
mented myomatous neurocristoma, ganglioneuro-
ma, and benign and malignant schwannoma [17].
Currently, the definitive diagnosis of PNET is given
by positive staining with CD99 and translocation
t(11;22)(q24;q12).
To date, there is no standard treatment for pPNETs.
Hysterectomy and lymph node dissection followed by
radiation and chemotherapy are commonly used.
Chemotherapy may have played a role in the patient
described by Rose et al, who had metastatic tumors
in 10 of 13 pelvic lymph nodes. Postoperatively, this
patient was treated with a combination of vincris-
tine, cisplatin, daunorubicin, dactinomycin, cyclophos-
phamide, and VP-16 and was disease-free for 5.5 years
postoperatively [20]. Another patient, reported by
Ward et al, received the same regimen and was doing
well after 10 years of follow-up [1].
Though the prognosis of uterine pPNET is poor, we
believe that aggressive surgical treatment and adju-
vant chemotherapy are warranted. Postoperative radio-
therapy could be carried out but its effectiveness remains
uncertain.
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